Cargando…
Addressing Therapeutic Inertia in 2020 and Beyond: A 3-Year Initiative of the American Diabetes Association
Research has shown that getting to glycemic targets early on leads to better outcomes in people with type 2 diabetes; yet, there has been no improvement in the attainment of A1C targets in the past decade. One reason is therapeutic inertia: the lack of timely adjustment to the treatment regimen when...
Autores principales: | Gabbay, Robert A., Kendall, Debbie, Beebe, Christine, Cuddeback, John, Hobbs, Todd, Khan, Naeem D., Leal, Sandra, Miller, Eden, Novak, Lucia M., Rajpathak, Swapnil N., Scribner, Paul, Meneghini, Luigi, Khunti, Kamlesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566926/ https://www.ncbi.nlm.nih.gov/pubmed/33132507 http://dx.doi.org/10.2337/cd20-0053 |
Ejemplares similares
-
Therapeutic inertia in type 2 diabetes: prevalence, causes, consequences and
methods to overcome inertia
por: Khunti, Sachin, et al.
Publicado: (2019) -
Addressing the Inertia: A Holistic Approach to Diabetic Foot Evaluation
por: Swain, Jayshree, et al.
Publicado: (2023) -
Addressing Therapeutic Inertia: Development and Implementation of an Electronic Health Record–Based Diabetes Intensification Tool
por: Pantalone, Kevin M., et al.
Publicado: (2023) -
Metformin adherence and discontinuation among patients with type 2 diabetes: A retrospective cohort study
por: Tang, Yuexin, et al.
Publicado: (2020) -
Diagnostic inertia in dyslipidaemia: results of a preventative programme in Spain
por: Palazón-Bru, Antonio, et al.
Publicado: (2015)